Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz

Ali Tamer; Oğuz Karabay; Ahmet Genç

Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz

Year 2015, Volume: 5 Issue: 3, 155 - 158, 11.12.2015

https://izlik.org/JA59KE52CN

Abstract

Trombositoz tombosit sayısının 400.000/mm3 üzerinde olması olarak tanımlanır. İlaçlar sekonder trombositoz (ST) etyolojisinde yer almaktadır. Bu sunumda siprofloksasin tedavisi sırasında ekstrem trombositoz gelişen 23 yaşındaki bayan olguyu sunmayı amaçladık.

Keywords

Trombositoz , Siprofloksasin

References

Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003; 14: 329-331.
Wiwanitkit V. Extreme thrombocytosis: what are the etiologies? Clin Appl Thromb Hemost. 2006; 12: 85–87.
Yang CJ, Hwang JJ, Hung JY, Chong IW, Huang MS. Extreme thrombocytosis under the treatment by amoxicillin/ clavulanate. Pharm World Sci. 2006; 28: 326–328.
Yangco BG, Kenyon VS, Halkias KD, Bogel JA, Toney JF, Chmel H. Oral ciprofloxacin treatment of infections in geriatric patients. Clin Ther. 1989; 11: 503-510.
Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010; 149: 352-375.
Osovsky M, Tamary H, Merlob P. Neonatal thrombocytosis following G-CSF treatment. Clinical Toxicology 2007; 45: 801–802.
Chen HC, Wang CY, Wang CS. Marked thrombocytosis during treatment with ceftazidime for pulmonary infection. Pharm World Sci. 2008; 30: 70–72.
Frye JL, Thompson DF. Drug-induced thrombocytosis. J Clin Pharm Ther 1993; 18: 45-48.
Tonbul A, Uras N, Tayman C, Halici T, Polat A, Mansur Tatli M. Thrombocytosis associated with enoxaparin: A very rare cause in newborns. Platelets. 2010; 21: 300-302.
Nako Y, Tachibana A, Fujiu T, Tomomasa T, Morikawa A. Neonatal thrombocytosis resulting from the maternal use of non-narcotic antischizophrenic drugs during pregnancy Arch Dis Child Fetal Neonatal Ed. 2001; 84: 198-200.
Parry MF, Jacobs B, Scully B, Neu HC. Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibiotics. Diagn Microbiol Infect Dis. 1984; 2: 229-231.
-
Bertino J, Fish D. The Safety Profile of the Fluoroquinolones. Clinical therapeutics 2000; 22: 798-817.

Year 2015, Volume: 5 Issue: 3, 155 - 158, 11.12.2015

Ali Tamer , Oğuz Karabay Ahmet Genç

https://izlik.org/JA59KE52CN

Abstract

References

Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003; 14: 329-331.
Wiwanitkit V. Extreme thrombocytosis: what are the etiologies? Clin Appl Thromb Hemost. 2006; 12: 85–87.
Yang CJ, Hwang JJ, Hung JY, Chong IW, Huang MS. Extreme thrombocytosis under the treatment by amoxicillin/ clavulanate. Pharm World Sci. 2006; 28: 326–328.
Yangco BG, Kenyon VS, Halkias KD, Bogel JA, Toney JF, Chmel H. Oral ciprofloxacin treatment of infections in geriatric patients. Clin Ther. 1989; 11: 503-510.
Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010; 149: 352-375.
Osovsky M, Tamary H, Merlob P. Neonatal thrombocytosis following G-CSF treatment. Clinical Toxicology 2007; 45: 801–802.
Chen HC, Wang CY, Wang CS. Marked thrombocytosis during treatment with ceftazidime for pulmonary infection. Pharm World Sci. 2008; 30: 70–72.
Frye JL, Thompson DF. Drug-induced thrombocytosis. J Clin Pharm Ther 1993; 18: 45-48.
Tonbul A, Uras N, Tayman C, Halici T, Polat A, Mansur Tatli M. Thrombocytosis associated with enoxaparin: A very rare cause in newborns. Platelets. 2010; 21: 300-302.
Nako Y, Tachibana A, Fujiu T, Tomomasa T, Morikawa A. Neonatal thrombocytosis resulting from the maternal use of non-narcotic antischizophrenic drugs during pregnancy Arch Dis Child Fetal Neonatal Ed. 2001; 84: 198-200.
Parry MF, Jacobs B, Scully B, Neu HC. Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibiotics. Diagn Microbiol Infect Dis. 1984; 2: 229-231.
-
Bertino J, Fish D. The Safety Profile of the Fluoroquinolones. Clinical therapeutics 2000; 22: 798-817.

There are 13 citations in total.

Details

Primary Language	Turkish
Authors	Ali Tamer Oğuz Karabay This is me Ahmet Genç This is me
Submission Date	December 6, 2015
Publication Date	December 11, 2015
IZ	https://izlik.org/JA59KE52CN
Published in Issue	Year 2015 Volume: 5 Issue: 3

Cite

APA	Tamer, A., Karabay, O., & Genç, A. (2015). Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz. Sakarya Medical Journal, 5(3), 155-158. https://izlik.org/JA59KE52CN
AMA	1.Tamer A, Karabay O, Genç A. Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz. Sakarya Medical Journal. 2015;5(3):155-158. https://izlik.org/JA59KE52CN
Chicago	Tamer, Ali, Oğuz Karabay, and Ahmet Genç. 2015. “Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz”. Sakarya Medical Journal 5 (3): 155-58. https://izlik.org/JA59KE52CN.
EndNote	Tamer A, Karabay O, Genç A (December 1, 2015) Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz. Sakarya Medical Journal 5 3 155–158.
IEEE	[1]A. Tamer, O. Karabay, and A. Genç, “Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz”, Sakarya Medical Journal, vol. 5, no. 3, pp. 155–158, Dec. 2015, [Online]. Available: https://izlik.org/JA59KE52CN
ISNAD	Tamer, Ali - Karabay, Oğuz - Genç, Ahmet. “Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz”. Sakarya Medical Journal 5/3 (December 1, 2015): 155-158. https://izlik.org/JA59KE52CN.
JAMA	1.Tamer A, Karabay O, Genç A. Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz. Sakarya Medical Journal. 2015;5:155–158.
MLA	Tamer, Ali, et al. “Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz”. Sakarya Medical Journal, vol. 5, no. 3, Dec. 2015, pp. 155-8, https://izlik.org/JA59KE52CN.
Vancouver	1.Ali Tamer, Oğuz Karabay, Ahmet Genç. Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz. Sakarya Medical Journal [Internet]. 2015 Dec. 1;5(3):155-8. Available from: https://izlik.org/JA59KE52CN